GR1006419B - Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων - Google Patents

Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων

Info

Publication number
GR1006419B
GR1006419B GR20080100206A GR20080100206A GR1006419B GR 1006419 B GR1006419 B GR 1006419B GR 20080100206 A GR20080100206 A GR 20080100206A GR 20080100206 A GR20080100206 A GR 20080100206A GR 1006419 B GR1006419 B GR 1006419B
Authority
GR
Greece
Prior art keywords
ursolic acid
wounds
preparation
treatment
destined
Prior art date
Application number
GR20080100206A
Other languages
English (en)
Inventor
Γεωργιος Καλλιμανης
Original Assignee
Γεωργιος Καλλιμανης
Καλλιμανης Δημητριος
Καλλιμανης Παναγιωτης
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Γεωργιος Καλλιμανης, Καλλιμανης Δημητριος, Καλλιμανης Παναγιωτης filed Critical Γεωργιος Καλλιμανης
Priority to GR20080100206A priority Critical patent/GR1006419B/el
Publication of GR1006419B publication Critical patent/GR1006419B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Νέο φάρμακο για τη θεραπεία των εγκαυμάτων με δραστικό συστατικό ουρσολικό οξύ (Ursolic acid), εξ απομονώσεως από φυτά και τα κατάλληλα έκδοχα για την παρασκευή αλοιφής. Με το σκεύασμα αυτό, τοπικής εφαρμογής, επιτυγχάνεται η ταχεία εξάλειψη του καύσωνος, πόνου και λοιπών συμπτωμάτων και η ομαλή ανάπλαση - αποκατάσταση της πάσχουσας περιοχής του δέρματος. Με την παρούσα θεραπεία δεν εγκαταλείπονται δυσμορφίες ή παραμορφώσεις λόγω του εγκαύματος. Παρενέργειες δεν παρατηρήθηκαν. Συνδυασμοί με άλλα φάρμακα δεν χρειάστηκαν.
GR20080100206A 2008-03-28 2008-03-28 Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων GR1006419B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20080100206A GR1006419B (el) 2008-03-28 2008-03-28 Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20080100206A GR1006419B (el) 2008-03-28 2008-03-28 Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων

Publications (1)

Publication Number Publication Date
GR1006419B true GR1006419B (el) 2009-06-01

Family

ID=40863448

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20080100206A GR1006419B (el) 2008-03-28 2008-03-28 Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων

Country Status (1)

Country Link
GR (1) GR1006419B (el)

Similar Documents

Publication Publication Date Title
PH12013501790B1 (en) Use of dpp iv inhibitors
WO2011107750A3 (en) Delayed prolonged drug delivery
WO2011107755A3 (en) Immediate/delayed drug delivery
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
EA201390409A1 (ru) Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
WO2012092458A3 (en) Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
WO2011069141A3 (en) Interferon therapies in combination with blockade of stat3 activation
EA201170669A1 (ru) Лечение пирфенидоном пациентов с атипичной функцией печени
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
BRPI1007945A2 (pt) Composição farmacêutica, comprimido, e, métodos de tratar um paciente sofrendo de hepatite c, de reduzir um ou mais dos efeitos colaterais associados ao tratamento com nitazoxanida ou tizoxanida em um paciente, de aumentar a biodisponibilidade de nitazoxinida ou de um seu análogo em um paciente, e de prolongar a absorção de nitazoxanida ou de um seu análogo em um paciente
NZ719520A (en) Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
MX352824B (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
PH12014501620A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
PH12014501579A1 (en) Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers
WO2015003122A3 (en) Regulation of glucose metabolism using anti-cgrp antibodies
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
BR112012028153A2 (pt) composição farmacêutica e método para o tratamento de hipertensão
GR1006419B (el) Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ για τη θεραπεια των εγκαυματων

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120905